Study on the Safety of Abatacept in Relapsing Polychondritis

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

NCT00124982 ·Status: COMPLETED ·Phase: PHASE3

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

NCT02885818 ·Status: COMPLETED

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00420199 ·Status: COMPLETED ·Phase: PHASE3

Abatacept With Methotrexate- Phase IIB

NCT00162266 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT02722694 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

NCT03882008 ·Status: COMPLETED ·Phase: PHASE4

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

NCT01786668 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

NCT00162201 ·Status: COMPLETED ·Phase: PHASE1

A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate

NCT00345748 ·Status: COMPLETED ·Phase: PHASE2

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

NCT01960855 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

NCT03178487 ·Status: COMPLETED ·Phase: PHASE2

Abatacept Treatment in Polymyositis and Dermatomyositis

NCT01315938 ·Status: COMPLETED ·Phase: PHASE2

ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

NCT04795141 ·Status: TERMINATED ·Phase: PHASE2

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

NCT00122382 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

NCT03670667 ·Status: COMPLETED

Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

NCT02805010 ·Status: UNKNOWN ·Phase: PHASE1

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

NCT02504268 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

NCT01088360 ·Status: ACTIVE_NOT_RECRUITING

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

NCT02037737 ·Status: COMPLETED

Safety Study of Abatacept to Treat Rheumatoid Arthritis

NCT01247766 ·Status: COMPLETED

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

NCT02629159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

NCT02066389 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197

NCT02429895 ·Status: TERMINATED ·Phase: PHASE2

Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS

NCT03632187 ·Status: UNKNOWN ·Phase: PHASE3

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)

NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2